Home » Topics » Regulatory

Regulatory
RSS

Prograf approved for new indication in Japan, launched in France

April 26, 1996

MitoExtra enters clinical trials

April 26, 1996

Hyal-CT1101 effective in phase III trial

April 26, 1996

FDA approves Prilosec + Biaxin combination for H. pylori

April 19, 1996

Zanidip approved for marketing in U.K.

April 19, 1996

FDA approves new indication for Pravachol

April 19, 1996

Vaqta gets the green light from FDA

April 12, 1996

Improved Havrix approved by FDA

April 12, 1996

Carbonic anhydrase inhibitor tested for parkinsonism

April 12, 1996

Genentech files for new indication for alteplase

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...